EIDD-2801 | B2725

EIDD-2801 is an orally bioavailable prodrug of the potent ribonucleoside analog EIDD-1931. EIDD-2801 displays broad spectrum antiviral activity against influenza virus and multiple coronaviruses, such as SARS-CoV-2, MERS-CoV, SARS-CoV. EIDD-2801 could be potentially useful for COVID-19 treatment.

EIDD-2801 is an orally bioavailable prodrug of the potent ribonucleoside analog EIDD-1931. EIDD-2801 displays broad spectrum antiviral activity against influenza virus and multiple coronaviruses, such as SARS-CoV-2, MERS-CoV, SARS-CoV. EIDD-2801 could be potentially useful for COVID-19 treatment.

B2725 | EIDD-2801 DataSheet

Alternate Name/Synonyms: EIDD2801,((2R,3S,4R,5R)-3,4-dihydroxy-5-((E)-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl isobutyrate

Appearance: White to off-white solid

Formulation:

CAS Number: 2349386-89-4

Structure Available?: Yes

Peptide sequence: N/A

Salt Form: No

Molecular Formula: C₁₃H₁₉N₃O₇

Molecular Weight: 329.31

Cell-Permeable?: TRUE

Purity: ≥98%

Solubilities: ~25 mg/ml DMSO

Handling: Do not take internally. Wear gloves and mask when handling the product! Avoid contact by all modes of exposure.

Country of Origin: USA

Tag Line: An antiviral agent

MDL Number:

PubChem CID: 145996610

SMILES: CC(C)C(=O)OCC1C(C(C(O1)N2C=CC(=NC2=O)NO)O)O

InChi: InChI=1S/C13H19N3O7/c1-6(2)12(19)22-5-7-9(17)10(18)11(23-7)16-4-3-8(15-21)14-13(16)20/h3-4,6-7,9-11,17-18,21H,5H2,1-2H3,(H,14,15,20)/t7-,9-,10-,11-/m1/s1

InChi Key: HTNPEHXGEKVIHG-QCNRFFRDSA-N